These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1376329)

  • 1. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.
    Giebel LB; Spritz RA
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8696-9. PubMed ID: 1717985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human piebaldism: six novel mutations of the proto-oncogene KIT.
    Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
    Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the c-kit protooncogene in the human developmental defect piebald trait.
    Fleischman RA; Saltman DL; Stastny V; Zneimer S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10885-9. PubMed ID: 1720553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of the KIT and PDGFRA genes in a patient with piebaldism.
    Spritz RA; Droetto S; Fukushima Y
    Am J Med Genet; 1992 Nov; 44(4):492-5. PubMed ID: 1279971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Giebel LB; Holmes SA
    Am J Hum Genet; 1992 Feb; 50(2):261-9. PubMed ID: 1370874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.
    Spritz RA; Holmes SA; Ramesar R; Greenberg J; Curtis D; Beighton P
    Am J Hum Genet; 1992 Nov; 51(5):1058-65. PubMed ID: 1384325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism.
    Fleischman RA; Gallardo T; Mi X
    J Invest Dermatol; 1996 Nov; 107(5):703-6. PubMed ID: 8875953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel KIT missense mutation in one Chinese family with piebaldism.
    Yin XY; Ren YQ; Yang S; Xu SX; Zhou FS; Du WH; Lin D; Wang PG; Zhang SM; Zhang XJ
    Arch Dermatol Res; 2009 Jun; 301(5):387-9. PubMed ID: 19430803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel KIT gene mutation from a family with piebaldism in the southern part of China].
    Deng WP; Huang YS; Lu C; Lan W; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):668-70. PubMed ID: 16331568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism.
    Ezoe K; Holmes SA; Ho L; Bennett CP; Bolognia JL; Brueton L; Burn J; Falabella R; Gatto EM; Ishii N
    Am J Hum Genet; 1995 Jan; 56(1):58-66. PubMed ID: 7529964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel KIT gene mutation results in piebaldism].
    Deng WP; Lu C; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):545-7. PubMed ID: 16220461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New KIT mutations in patients with piebaldism.
    Murakami T; Fukai K; Oiso N; Hosomi N; Kato A; Garganta C; Barnicoat A; Poppelaars F; Aquaron R; Paller AS; Ishii M
    J Dermatol Sci; 2004 Jun; 35(1):29-33. PubMed ID: 15194144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural organization of the murine c-kit proto-oncogene.
    Gokkel E; Grossman Z; Ramot B; Yarden Y; Rechavi G; Givol D
    Oncogene; 1992 Jul; 7(7):1423-9. PubMed ID: 1377813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.
    Spritz RA; Holmes SA; Itin P; Küster W
    J Invest Dermatol; 1993 Jul; 101(1):22-5. PubMed ID: 7687267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of c-kit gene integrity in aplastic anemia.
    Paquette RL; Hsu NC; Koeffler HP
    Blood Cells Mol Dis; 1996; 22(2):159-68. PubMed ID: 8931956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse W/c-kit locus.
    Bernstein A; Chabot B; Dubreuil P; Reith A; Nocka K; Majumder S; Ray P; Besmer P
    Ciba Found Symp; 1990; 148():158-66; discussion 166-72. PubMed ID: 1690623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.